Soo-Jung Lee

12PUBLICATIONS
28CO-AUTHORS
PharmacogenomicsMolecular medicineToxicology (incl. clinical toxicology)Gene and molecular therapyGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 16, 2024
The Potential Role of Aripiprazole Augmentation for Major Depressive Disorder with Anxious Distress in Naturalistic Treatment Setting.

Seung-Hoon Lee, Kyung Ho Lee, Tae Sun Han

|Jul 10, 2023
Additional Clinical Benefit of Agomelatine Treatment for Major Depressive Disorder in Naturalistic Treatment Setting.

Kyung Ho Lee, Tae Sun Han, Changsu Han

|Oct 25, 2021
Exploring Hidden Issues in the Use of Antipsychotic Polypharmacy in the Treatment of Schizophrenia.

Jung-Jin Kim, Chi-Un Pae, Changsu Han

|Jul 23, 2021
Consideration of Long-Acting Injectable Antipsychotics for Polypharmacy Regimen in the Treatment of Schizophrenia: Put It on the Table or Not?

Chi-Un Pae, Changsu Han, Won-Myong Bahk

|Apr 23, 2021
Clinical Benefit and Utility of Switching to Aripiprazole Once Monthly in Patients with Antipsychotic Polypharmacy or Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study.

Chi-Un Pae, Changsu Han, Won-Myong Bahk

|Jan 28, 2021
A Practical Utility and Benefit of Pharmacogenetic-based Antidepressant Treatment Strategy for Major Depressive Disorder Patients with Difficult-to-treat.

Kyung Ho Lee, Won-Myong Bahk, Soo-Jung Lee

Pageof 2

Frequent Collaborators

11 joint publications

Chi-Un Pae

9 joint publications

Won-Myong Bahk

8 joint publications

Changsu Han

8 joint publications

Ashwin Patkar